Back to Awarded Treatment Trials
Awarded Trial: 03T-337
Grant ID
03T-337
Illness
Schizophrenia
Primary Drug/Intervention
Suberoylanilide Hydroxamic Acid
Primary Dosage
N/A
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Terminated
Investigator
Potkin
Sample Size
70
Duration of Study Period for Each Subject
4-6 weeks
Outcome Measurements
PANSS, Calgary Depression Scale, ESRS, Barnes Akathisia Scale
Results
Grant terminated in November 2004 due to poor brain availability of the drug.
Publication
N/A
Link
N/A
PI Name
Steven Potkin
Degree
MD
Center
Department of Psychiatry and Human Behavior
Institution
University of California
Address
University of California, Room 161
City or Town
Irvine
State or Province
CA
Zip or Postal Code
92697
Country
USA
Email Address
sgpotkin@uci.edu